Suppr超能文献

血小板与淋巴细胞比值降低可预测寡转移性结直肠癌患者的良好预后:一项单中心队列回顾性研究。

The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study.

作者信息

Huang Xiaojuan, Cui Jin, Li Xiaohui, Liu Chao, Sun Jujie, Yue Jinbo

机构信息

Clinical Medical College, Southwest Medical University, Luzhou, Sichuan, China.

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.

出版信息

World J Surg Oncol. 2021 Oct 13;19(1):297. doi: 10.1186/s12957-021-02406-z.

Abstract

BACKGROUND

Inflammation markers have an important effect on tumor proliferation, invasion, and metastasis. Oligometastatic disease (OMD) is an intermediate state between widespread metastases and locally confined disease, where curative strategies may be effective for some patients. We aimed to explore the predictive value of inflammatory markers in patients with oligometastatic colorectal cancer (OMCC) and build a nomogram to predict the prognosis of these patients.

METHODS

Two hundred nine patients with OMCC were retrospectively collected in this study. The Kaplan-Meier survival curves and Cox regression analysis were used to estimate overall survival (OS) and progression-free survival (PFS). A multivariate Cox analysis model was utilized to establish the nomogram. The concordance index (C-index), calibration curve, and receiver operating characteristics (ROC) were established to verify the validity and accuracy of the prediction model.

RESULTS

According to the multivariate analysis, decreased platelet-to-lymphocyte ratio (PLR) might independently improve OS in patients with OMCC (HR = 2.396, 95% CI 1.391-4.126, P = 0.002). Metastases of extra-regional lymph nodes indicated poor OS (HR = 2.472, 95% CI 1.247-4.903, P = 0.010). While the patients with early N stage had better OS (HR = 4.602, 95% CI 2.055-10.305, P = 0.001) and PFS (HR = 2.100, 95% CI 1.364-3.231, P = 0.007). Primary tumor resection (HR = 0.367, 95% CI 0.148-0.908, P = 0.030) and lower fibrinogen (HR = 2.254, 95% CI 1.246-4.078, P = 0.007) could significantly prolong the OS in patients with OMCC. PLR, metastases of extra-regional lymph nodes, N stage, primary tumor resection, and fibrinogen were used to make up the nomogram. The C-index and area under the curve (AUC) of the ROC in nomogram were 0.721 and 0.772 respectively for OS, showed good consistency between predictive probability of OS and actual survival.

CONCLUSIONS

Decreased PLR could predict a good prognosis in patients with OMCC. The nomogram including inflammatory factors and clinicopathological markers was credible and accurate to predict survivals in patients with OMCC.

摘要

背景

炎症标志物对肿瘤的增殖、侵袭和转移具有重要影响。寡转移疾病(OMD)是广泛转移和局部局限性疾病之间的中间状态,对于某些患者,治愈性策略可能有效。我们旨在探讨炎症标志物在寡转移结直肠癌(OMCC)患者中的预测价值,并构建一个列线图来预测这些患者的预后。

方法

本研究回顾性收集了209例OMCC患者。采用Kaplan-Meier生存曲线和Cox回归分析来评估总生存期(OS)和无进展生存期(PFS)。利用多变量Cox分析模型建立列线图。建立一致性指数(C-index)、校准曲线和受试者工作特征(ROC)曲线以验证预测模型的有效性和准确性。

结果

根据多变量分析,血小板与淋巴细胞比值(PLR)降低可能独立改善OMCC患者的OS(HR = 2.396,95%CI 1.391 - 4.126,P = 0.002)。区域外淋巴结转移提示OS较差(HR = 2.472,95%CI 1.247 - 4.903,P = 0.010)。而N分期较早的患者OS较好(HR = 4.602,95%CI 2.055 - 10.305,P = 0.001)和PFS较好(HR = 2.100,95%CI 1.364 - 3.231,P = 0.007)。原发肿瘤切除(HR = 0.367,95%CI 0.148 - 0.908,P = 0.030)和较低的纤维蛋白原水平(HR = 2.254,95%CI 1.246 - 4.078,P = 0.007)可显著延长OMCC患者的OS。PLR、区域外淋巴结转移、N分期、原发肿瘤切除和纤维蛋白原用于构建列线图。列线图中OS的C-index和ROC曲线下面积(AUC)分别为0.721和0.772,显示OS的预测概率与实际生存率之间具有良好的一致性。

结论

PLR降低可预测OMCC患者的良好预后。包含炎症因子和临床病理标志物的列线图在预测OMCC患者生存率方面是可靠且准确的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d599/8513170/fac78e602c44/12957_2021_2406_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验